FLGT — Fulgent Genetics, Inc. stock price, charts and financials

QT47Fulgent Genetics, Inc.

Fulgent Genetics, Inc. (NASDAQ: FLGT) is a Healthcare company in the Medical - Diagnostics & Research industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
18.55
+0.94+5.34%
OverviewShort InterestFilings
FLGTQT47Fulgent Genetics, Inc.·NASDAQ
18.55+5.34%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 30, 20268-KCurrent report
Jul 30, 202610-QQuarterly report
Jul 28, 20264Statement of changes in beneficial ownership
Jul 28, 20264Statement of changes in beneficial ownership
Jul 28, 20264Statement of changes in beneficial ownership
Jun 02, 20268-KCurrent report
May 28, 20264Statement of changes in beneficial ownership
May 28, 20264Statement of changes in beneficial ownership
May 28, 20264Statement of changes in beneficial ownership
May 27, 20264Statement of changes in beneficial ownership
May 27, 2026SC 13D/ABeneficial ownership statement (active, amended)
May 21, 20268-KCurrent report
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 14, 20268-KCurrent report
May 14, 2026S-8Registration of employee benefit securities
Apr 28, 20264Statement of changes in beneficial ownership
Apr 28, 20264Statement of changes in beneficial ownership
Apr 28, 20264Statement of changes in beneficial ownership
Mar 31, 2026DEFA14AAdditional proxy soliciting materials
Mar 31, 20264/AStatement of changes in beneficial ownership (amended)
Mar 31, 2026DEF 14ADefinitive proxy statement
Mar 31, 2026ARSAnnual report to shareholders
Mar 31, 2026SC 13D/ABeneficial ownership statement (active, amended)
#1 / 25 of 409
Page
▼
/ 17